Disclosure Of Entity's Operating Segments [Text Block]

Biocartis Group NV - Filing #3123157

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
48,269,000 EUR
43,128,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
659,000 EUR
532,000 EUR
Tax expense (income)
243,000 EUR
228,000 EUR
Profit (loss) before tax
71,715,000 EUR
63,162,000 EUR
Profit (loss)
71,472,000 EUR
71,472,000 EUR
71,472,000 EUR
62,934,000 EUR
62,934,000 EUR
62,934,000 EUR
Assets
142,480,000 EUR
210,517,000 EUR
Cash flows from (used in) operating activities
65,716,000 EUR
39,267,000 EUR
Cash flows from (used in) investing activities
3,748,000 EUR
4,007,000 EUR
Cash flows from (used in) financing activities
1,204,000 EUR
11,523,000 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.